Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 14/20 | 1.00 |
| ▸ | CYP11B2 | P19099 | 12/20 | 0.74 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.74 |
| ▸ | QPCT | Q16769 | 1/20 | 0.74 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.74 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.74 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.71 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.71 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1024261 | 0.91 | CYP11B1 (0.84) | CYP11B1CYP11B2CYP19A1CYP1A2POLB | |
| Hydrochloric Acid SCHEMBL1775141 | 0.89 | CYP11B1 (0.81) | CYP11B1CYP11B2CYP19A1CYP1A2POLB | |
| SCHEMBL22063900 | 0.85 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP19A1CYP1A2POLB | |
| Benzylimidazole SCHEMBL414 | 0.85 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP19A1CYP1A2POLB | |
| SCHEMBL2529997 | 0.85 | CYP11B1 (0.86) | CYP11B1CYP11B2CYP19A1CYP1A2POLB | |
| SCHEMBL6057476 | 0.85 | CYP11B1 (0.75) | CYP11B1CYP11B2CYP19A1CYP1A2POLB | |
| Benzylimidazole SCHEMBL27803894 | 0.84 | CYP11B1 (0.89) | CYP11B1CYP11B2CYP19A1CYP1A2POLB | |
| Benzylimidazole SCHEMBL16237308 | 0.83 | CYP11B1 (0.96) | CYP11B1CYP11B2CYP19A1CYP1A2POLB | |
| SCHEMBL570342 | 0.83 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP19A1CYP1A2POLB | |
| Benzylimidazole SCHEMBL31453527 | 0.83 | CYP11B1 (0.96) | CYP11B1CYP11B2CYP19A1CYP1A2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230143425-A1 | IMPROVEMENTS RELATED TO SORBENT MEDIA | GENESIS SYSTEMS LLC | 2023-05-11 | — | — | US | disclosed |
| EP-3854475-A1 | IMPROVEMENTS RELATED TO SORBENT MEDIA | Molecule RND Limited (IE) | 2021-07-28 | — | — | EP | disclosed |
| EP-3854471-A1 | IMPROVEMENTS RELATING TO WATER PURIFICATION | Molecule RND Limited (IE) | 2021-07-28 | — | — | EP | disclosed |
| US-20210162338-A1 | WATER CAPTURE | THE UNIVERSITY OF LIMERICK (IE) | 2021-06-03 | — | — | US | disclosed |
| US-20200030737-A1 | WATER CAPTURE METHODS, DEVICES, AND COMPOUNDS | UNIV LIMERICK (IE) | 2020-01-30 | — | — | US | disclosed |
| WO-2020021112-A1 | IMPROVEMENTS RELATING TO WATER CAPTURE | UNIVERSITY OF LIMERICK (IE) | 2020-01-30 | — | — | WO | disclosed |
| EP-3599019-A1 | IMPROVEMENTS RELATING TO WATER CAPTURE | University of Limerick (IE) | 2020-01-29 | — | — | EP | disclosed |
| US-9394290-B2 | Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases | UNIVERSITAET DES SAARLANDES CAMPUS SAARBRUECKEN (DE) | 2016-07-19 | — | — | US | disclosed |
| US-9394290-B2 | Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases | UNIVERSITAET DES SAARLANDES CAMPUS SAARBRUECKEN (DE) | 2016-07-19 | — | — | US | disclosed |
| US-9394290-B2 | Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases | UNIVERSITAET DES SAARLANDES CAMPUS SAARBRUECKEN (DE) | 2016-07-19 | — | — | US | disclosed |
| EP-2630136-A1 | SELECTIVE CYP11B1 INHIBITORS FOR THE TREATMENT OF CORTISOL DEPENDENT DISEASES | Universität des Saarlandes (DE) | 2013-08-28 | — | — | EP | disclosed |
| WO-2012052540-A1 | SELECTIVE CYP11B1 INHIBITORS FOR THE TREATMENT OF CORTISOL DEPENDENT DISEASES | UNIVERSITAET DES SAARLANDES (DE) | 2012-04-26 | — | — | WO | disclosed |
| WO-2012052540-A1 | SELECTIVE CYP11B1 INHIBITORS FOR THE TREATMENT OF CORTISOL DEPENDENT DISEASES | UNIVERSITAET DES SAARLANDES (DE) | 2012-04-26 | — | — | WO | disclosed |
| US-5856343-A | Imidazolylmethyl-pyridines used for senile dementia | NOVARTIS AG (CH) | 1999-01-05 | — | — | US | disclosed |
| US-5635521-A | DRUGS TREATING ALZHEIMER'S DISEASE | SANDOZ LTD. (CH) | 1997-06-03 | — | — | US | disclosed |
| EP-0534904-B1 | Imidazolylmethyl-pyridines | SANDOZ LTD (CH) | 1996-10-23 | — | — | EP | disclosed |
| EP-0534904-A1 | Imidazolylmethyl-pyridines | SANDOZ LTD. (CH) | 1993-03-31 | — | — | EP | disclosed |
| EP-0159011-B1 | CEPHALOSPORIN DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DAIICHI SEIYAKU CO., LTD. (JP) | 1989-08-02 | — | — | EP | disclosed |
| US-4833242-A | ANTIBIOTICS, BACTERICIDES | DAIICHI SEIYAKU CO., LTD. (JP) | 1989-05-23 | — | — | US | disclosed |
| EP-0159011-A2 | Cephalosporin derivatives, process for preparing them and pharmaceutical compositions containing them | DAIICHI SEIYAKU CO., LTD. (JP) | 1985-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200030737-A1 | WATER CAPTURE METHODS, DEVICES, AND COMPOUNDS | AQP1, AQP3, AQP4 | CYP11B1 3902/4885CYP11B2 3610/4885CYP19A1 3272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.